...
首页> 外文期刊>Chemical Weekly >India, Uzbekistan summit to smoothen passage of pharma exports from India
【24h】

India, Uzbekistan summit to smoothen passage of pharma exports from India

机译:印度乌兹别克斯坦峰会,以简化印度药品出口的通道

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Uzbekistan, which holds vast potential for Indian pharmaceutical companies, and India will discuss export-import bottlenecks affecting bilateral trade and need for joint ventures in the sector, at a bilateral summit slated this month. In view of the growing potential for Indian firms in drugs and medical devices, the Department of Pharmaceuticals (DoP) has already launched an exercise to gather inputs about the problems faced by the pharma companies on the export front. The industry associations have been asked to forward the names of interested Indian companies for setting up joint ventures with Uzbek firms. The department will facilitate the ventures, with the help of other ministries. The bilateral issues, concerning the pharma and health sectors, are likely to be among the key areas of deliberations at the forthcoming 9th session of Indo-Uzbek Inter Government Commission (IUIGC) on trade, economic, scientific and technological cooperation to be held in Tashkent on May 4 and 5.
机译:对印度制药公司具有巨大潜力的乌兹别克斯坦,印度将在本月举行的双边峰会上讨论影响双边贸易的进出口瓶颈以及该领域合资企业的需求。鉴于印度公司在药品和医疗器械方面的潜力在不断增长,药品部(DoP)已启动一项活动,以收集有关制药公司在出口方面面临的问题的投入。已要求行业协会转发有兴趣的印度公司的名称,以便与乌兹别克斯坦公司建立合资企业。该部门将在其他部门的协助下为合资企业提供便利。与制药和卫生部门有关的双边问题可能是即将在塔什干举行的即将举行的印度-乌兹别克斯坦政府间委员会关于贸易,经济,科学和技术合作的第九届会议审议的关键领域。在5月4日和5日。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号